Anja Bauerfeind

2.7k total citations
28 papers, 588 citations indexed

About

Anja Bauerfeind is a scholar working on Public Health, Environmental and Occupational Health, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anja Bauerfeind has authored 28 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 4 papers in Dermatology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anja Bauerfeind's work include Reproductive Health and Contraception (12 papers), Dermatology and Skin Diseases (4 papers) and Pregnancy and Medication Impact (4 papers). Anja Bauerfeind is often cited by papers focused on Reproductive Health and Contraception (12 papers), Dermatology and Skin Diseases (4 papers) and Pregnancy and Medication Impact (4 papers). Anja Bauerfeind collaborates with scholars based in Germany, United States and United Kingdom. Anja Bauerfeind's co-authors include Stefan A. Loening, Dagmar Strohmeyer, Olaf Kaufmann, Jorge Esparza-Gordillo, Ingo Marenholz, Young‐Ae Lee, Franz Josef Strauß, Horst Schlechte, Georg Bartsch and Susanne Lau and has published in prestigious journals such as Genome Research, Journal of Allergy and Clinical Immunology and Human Molecular Genetics.

In The Last Decade

Anja Bauerfeind

25 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Bauerfeind Germany 12 163 147 142 140 103 28 588
Kotaro Kumano Japan 13 239 1.5× 200 1.4× 80 0.6× 41 0.3× 204 2.0× 20 820
Roohi Rasool India 15 228 1.4× 75 0.5× 35 0.2× 37 0.3× 56 0.5× 67 608
Eiichi Ishii Japan 11 70 0.4× 92 0.6× 30 0.2× 25 0.2× 123 1.2× 29 409
Anna Ragaz United States 9 102 0.6× 54 0.4× 38 0.3× 202 1.4× 64 0.6× 20 613
Mitsuhide Ohmichi Japan 13 128 0.8× 427 2.9× 38 0.3× 43 0.3× 478 4.6× 31 740
Ayça Kıykım Türkiye 13 78 0.5× 67 0.5× 63 0.4× 39 0.3× 109 1.1× 71 643
Lars Munksgaard Denmark 11 34 0.2× 62 0.4× 23 0.2× 60 0.4× 35 0.3× 27 628
Giovanni Lo Scocco Italy 12 52 0.3× 171 1.2× 38 0.3× 253 1.8× 40 0.4× 23 702
Marianna Ferrara Italy 14 94 0.6× 271 1.8× 40 0.3× 16 0.1× 54 0.5× 29 547
Baruch D. Jakubovic Canada 9 49 0.3× 65 0.4× 49 0.3× 52 0.4× 22 0.2× 15 338

Countries citing papers authored by Anja Bauerfeind

Since Specialization
Citations

This map shows the geographic impact of Anja Bauerfeind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Bauerfeind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Bauerfeind more than expected).

Fields of papers citing papers by Anja Bauerfeind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Bauerfeind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Bauerfeind. The network helps show where Anja Bauerfeind may publish in the future.

Co-authorship network of co-authors of Anja Bauerfeind

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Bauerfeind. A scholar is included among the top collaborators of Anja Bauerfeind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Bauerfeind. Anja Bauerfeind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bauerfeind, Anja, et al.. (2024). Venous Thromboembolic Risk of Estradiol Valerate–Dienogest Compared with Ethinyl Estradiol–Levonorgestrel Combined Oral Contraceptives. Obstetrics and Gynecology. 143(3). 431–434. 9 indexed citations
5.
Franke, Christian, et al.. (2024). Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across twelve European countries. Contraception. 132. 110375–110375. 2 indexed citations
6.
Becker, Kerstin, Anja Bauerfeind, Christian Franke, et al.. (2023). NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study. Gynecological Endocrinology. 39(1). 2166032–2166032. 6 indexed citations
7.
Donders, Gilbert, et al.. (2022). Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena® Satisfaction study. The European Journal of Contraception & Reproductive Health Care. 28(1). 1–9. 3 indexed citations
8.
9.
10.
Reed, Suzanne, Carol E. Koro, Julia DiBello, et al.. (2021). Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study. The European Journal of Contraception & Reproductive Health Care. 26(6). 447–453. 9 indexed citations
11.
Esparza-Gordillo, Jorge, Anja Matanovic, Ingo Marenholz, et al.. (2015). Maternal Filaggrin Mutations Increase the Risk of Atopic Dermatitis in Children: An Effect Independent of Mutation Inheritance. PLoS Genetics. 11(3). e1005076–e1005076. 32 indexed citations
12.
Rintisch, Carola, Matthias Heinig, Anja Bauerfeind, et al.. (2014). Natural variation of histone modification and its impact on gene expression in the rat genome. Genome Research. 24(6). 942–953. 40 indexed citations
13.
Marenholz, Ingo, Anja Bauerfeind, Jorge Esparza-Gordillo, et al.. (2011). The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Human Molecular Genetics. 20(12). 2443–2449. 29 indexed citations
14.
Marenholz, Ingo, Jorge Esparza-Gordillo, Anja Bauerfeind, et al.. (2011). Association Screening in the Epidermal Differentiation Complex (EDC) Identifies an SPRR3 Repeat Number Variant as a Risk Factor for Eczema. Journal of Investigative Dermatology. 131(8). 1644–1649. 61 indexed citations
15.
Zachariah, Rony, Katie Tayler‐Smith, Marcel Manzi, et al.. (2010). Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi.. PubMed. 14(2). 197–202. 7 indexed citations
16.
Marenholz, Ingo, Tamara Kerscher, Anja Bauerfeind, et al.. (2009). An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. Journal of Allergy and Clinical Immunology. 123(4). 911–916. 84 indexed citations
17.
Bauerfeind, Anja, Hans Knoblauch, Herbert Schuster, Friedrich C. Luft, & J. Reich. (2002). Single Nucleotide Polymorphism Haplotypes in the Cholesteryl-Ester Transfer Protein (CETP) Gene and Lipid Phenotypes. Human Heredity. 54(4). 166–173. 12 indexed citations
18.
Strohmeyer, Dagmar, et al.. (2000). Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. The Prostate. 42(1). 26–33. 87 indexed citations
19.
Follmann, Markus, Lothar Heinemann, Anja Bauerfeind, & Edeltraut Garbe. (2000). Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: results of a european case - control study. Pharmacoepidemiology and Drug Safety. 9(5). 417–422. 1 indexed citations
20.
Holtmann, Gerald, David Armstrong, E Pöppel, et al.. (1992). Influence of Stress on the Healing and Relapse of Duodenal Ulcers: A Prospective, Multicenter Trial of 2109 Patients with Recurrent Duodenal Ulceration Treated with Ranitidine. Scandinavian Journal of Gastroenterology. 27(11). 917–923. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026